|
Volumn 3, Issue 3, 2010, Pages 45-53
|
Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial
c
BioGeneriX AG
(Germany)
|
Author keywords
Cancer; Epoetin Beta; Epoetin Theta; Placebo; Symptomatic Anaemia
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
HEMOGLOBIN;
IRON;
PLACEBO;
PLATINUM DERIVATIVE;
RECOMBINANT ERYTHROPOIETIN;
ADULT;
AGED;
ANEMIA;
ARTICLE;
ASTHENIA;
BLOOD TRANSFUSION;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CHEMOTHERAPY INDUCED EMESIS;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPERTENSION;
LEUKOPENIA;
LOW DRUG DOSE;
LUNG SQUAMOUS CELL CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
NEOPLASM;
NEUTROPENIA;
OVARIAN EPITHELIAL CANCER;
OVARY CANCER;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN MANIFESTATION;
SOLID TUMOR;
STOMACH CANCER;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VOMITING;
|
EID: 78851470523
PISSN: None
EISSN: 17535174
Source Type: Journal
DOI: 10.1111/j.1753-5174.2010.00030.x Document Type: Article |
Times cited : (20)
|
References (9)
|